Unified Quality-Aware Compression and Pulse-Respiration Rates Estimation Framework for Reducing Energy Consumption and False Alarms of Wearable PPG Monitoring Devices

Due to the high demands of tiny, compact, lightweight, and low-cost photoplethysmogram (PPG) monitoring devices, these devices are resource-constrained including limited battery power. Consequently, it highly demands frequent charge or battery replacement in the case of continuous PPG sensing and transmission. Further, PPG signals are often severely corrupted under ambulatory and exercise recording conditions, leading to frequent false alarms. In this paper, we propose a unified quality-aware compression and pulse-respiration rates estimation framework for reducing energy consumption and false alarms of wearable and edge PPG monitoring devices by exploring predictive coding techniques for jointly performing signal quality assessment (SQA), data compression and pulse rate (PR) and respiration rate (RR) estimation without the use of different domains of signal processing techniques that can be achieved by using the features extracted from the smoothed prediction error signal. By using the five standard PPG databases, the performance of the proposed unified framework is evaluated in terms of compression ratio (CR), mean absolute error (MAE), false alarm reduction rate (FARR), processing time (PT) and energy saving (ES). The compression, PR, RR estimation, and SQA results are compared with the existing methods and results of uncompressed PPG signals with sampling rates of 125 Hz and 25 Hz. The proposed unified qualityaware framework achieves an average CR of 4%, SQA (Se of 92.00%, FARR of 84.87%), PR (MAE: 0.46 ±1.20) and RR (MAE: 1.75 (0.65-4.45), PT (sec) of 15.34 ±0.01) and ES of 70.28% which outperforms the results of uncompressed PPG signal with a sampling rate of 125 Hz. Arduino Due computing platformbased implementation demonstrates the real-time feasibility of the proposed unified quality-aware PRRR estimation and data compression and transmission framework on the limited computational resources. Thus, it has great potential in improving energy-efficiency and trustworthiness of wearable and edge PPG monitoring devices.publishedVersio

Neural net word representations for phrase-break prediction without a part of speech tagger

The use of shared projection neural nets of the sort used in language modelling is proposed as a way of sharing parameters between multiple text-to-speech system components. We experiment with pretraining the weights of such a shared projection on an auxiliary language modelling task and then apply the resulting word representations to the task of phrasebreak prediction. Doing so allows us to build phrase-break predictors that rival conventional systems without any reliance on conventional knowledge-based resources such as part of speech taggers. Index Terms — Speech synthesis, TTS, unsupervised learning, neural net language modelling, multitask learning

Risk of venous thromboembolism after total hip and knee replacement in older adults with comorbidity and co-occurring comorbidities in the Nationwide Inpatient Sample (2003-2006)

<p>Abstract</p> <p>Background</p> <p>Venous thromboembolism is a common, fatal, and costly injury which complicates major surgery in older adults. The American College of Chest Physicians recommends high potency prophylaxis regimens for individuals undergoing total hip or knee replacement (THR or TKR), but surgeons are reluctant to prescribe them due to fear of excess bleeding. Identifying a high risk cohort such as older adults with comorbidities and co-occurring comorbidities who might benefit most from high potency prophylaxis would improve how we currently perform preoperative assessment.</p> <p>Methods</p> <p>Using the Nationwide Inpatient Sample, we identified older adults who underwent THR or TKR in the U.S. between 2003 and 2006. Our outcome was VTE, including any pulmonary embolus or deep venous thrombosis. We performed multivariate logistic regression analyses to assess the effects of comorbidities on VTE occurrence. Comorbidities under consideration included coronary artery disease, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes, and cerebrovascular disease. We also examined the impact of co-occurring comorbidities on VTE rates.</p> <p>Results</p> <p>CHF increased odds of VTE in both the THR cohort (OR = 3.08 95% CI 2.05-4.65) and TKR cohort (OR = 2.47 95% CI 1.95-3.14). COPD led to a 50% increase in odds in the TKR cohort (OR = 1.49 95% CI 1.31-1.70). The data did not support synergistic effect of co-occurring comorbidities with respect to VTE occurrence.</p> <p>Conclusions</p> <p>Older adults with CHF undergoing THR or TKR and with COPD undergoing TKR are at increased risk of VTE. If confirmed in other datasets, these older adults may benefit from higher potency prophylaxis.</p

SARS-CoV-2 Testing and Positivity among Persons with and Without HIV in 6 US Cohorts

Background:It is not definitively known if persons with HIV (PWH) are more likely to be SARS-CoV-2 tested or test positive than persons without HIV (PWoH). We describe SARS-CoV-2 testing and positivity in 6 large geographically and demographically diverse cohorts of PWH and PWoH in the United States.Setting:The Corona Infectious Virus Epidemiology Team comprises 5 clinical cohorts within a health system (Kaiser Permanente Northern California, Oakland, CA; Kaiser Permanente Mid-Atlantic States, Rockville, MD; University of North Carolina Health, Chapel Hill, NC; Vanderbilt University Medical Center, Nashville, TN; and Veterans Aging Cohort Study) and 1 interval cohort (Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort Study).Methods:We calculated the proportion of patients SARS-CoV-2 tested and the test positivity proportion by HIV status from March 1 to December 31, 2020.Results:The cohorts ranged in size from 1675 to 31,304 PWH and 1430 to 3,742,604 PWoH. The proportion of PWH who were tested for SARS-CoV-2 (19.6%-40.5% across sites) was significantly higher than PWoH (14.8%-29.4%) in the clinical cohorts. However, among those tested, the proportion of patients with positive SARS-CoV-2 tests was comparable by HIV status; the difference in proportion of SARS-CoV-2 positivity ranged from 4.7% lower to 1.4% higher.Conclusions:Although PWH had higher testing proportions compared with PWoH, we did not find evidence of increased positivity in 6 large, diverse populations across the United States. Ongoing monitoring of testing, positivity, and COVID-19-related outcomes in PWH are needed, given availability, response, and durability of COVID-19 vaccines; emergence of SARS-CoV-2 variants; and latest therapeutic options